ALLMedicine™ Bacterial Vaginosis Center

Jan 15th, 2021 - Multiple studies have shown that oral or vaginal probiotics can effectively treat and prevent recurrent bacterial vaginosis. The dose, route, and treatment protocols vary greatly between studies, but many have shown a statistically significant red...

Dec 31st, 2020 - We aimed to determine if treatment of male sexual partners of women with recurrent BV with oral metronidazole twice daily for 7 days (i.e. multi-dose metronidazole) significantly decreased BV recurrence rates in the female. This was a multi-center...

Dec 23rd, 2020 - The vaginal microbiome plays a key role in women's reproductive health. Use of exogenous hormones, such as intramuscular depot-medroxyprogesterone acetate (DMPA-IM), may alter the composition of vaginal bacterial community. Vaginal swabs were coll...

Dec 21st, 2020 - Bacterial vaginosis (BV) is associated with increased risk of high-risk HPV (hrHPV), whereas Lactobacillus-dominated vaginal microbiotas are associated with reduced burden of hrHPV. Few epidemiologic studies have prospectively investigated the rel...

Dec 21st, 2020 - The aim of the study was to evaluate the performance of nucleic acid amplification testing (NAAT) for the diagnosis of vulvovaginal candidiasis (VVC), bacterial vaginosis, and Trichomonas vaginalis. A cross-sectional analysis of women with (n = 20...

Apr 7th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...

Oct 7th, 2019 - The USPSTF recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.

Jul 21st, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...

Jun 4th, 2015

May 23rd, 2015 - To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and com...

Jan 15th, 2021 - Multiple studies have shown that oral or vaginal probiotics can effectively treat and prevent recurrent bacterial vaginosis. The dose, route, and treatment protocols vary greatly between studies, but many have shown a statistically significant red...

Jan 7th, 2021 - SOLOSEC® is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in adult women. (1) To reduce the development of drug-resistant bacteria and maintain the effectiveness of SOLOSEC and other antibacterial drugs, SOLOSEC...

Dec 31st, 2020 - We aimed to determine if treatment of male sexual partners of women with recurrent BV with oral metronidazole twice daily for 7 days (i.e. multi-dose metronidazole) significantly decreased BV recurrence rates in the female. This was a multi-center...

Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...

Dec 23rd, 2020 - The vaginal microbiome plays a key role in women's reproductive health. Use of exogenous hormones, such as intramuscular depot-medroxyprogesterone acetate (DMPA-IM), may alter the composition of vaginal bacterial community. Vaginal swabs were coll...

Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Mar 29th, 2020 - Safety and next steps The safety analysis showed that side effects were generally mild and well tolerated. There were 161 adverse events among 29 women for whom safety data were available.

Oct 8th, 2019 - Insufficient evidence exists to recommend routine screening for pregnant women at higher risk of preterm birth for bacterial vaginosis, the U.S. Preventive Services Task Force (USPSTF) said. There was not enough evidence to determine the benefits ...